Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
14m agoInterContinental Hotels Group PLC Announces Transaction in Own Shares - April 30
15m agoMiscellaneous
18m agoQuarterly Activities Report - March 2026
47m agoAppendix 4C and Quarterly Activities Report - March 2026
1h agoDiagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
Bayer Ag Na logo

Bayer Ag Na

About

Bayer Ag Na (XETRA:BAYN) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 20 2026
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Apr 15 2026
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class
Apr 1 2026
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
Mar 31 2026
National Advertising Division Recommends Bayer Modify or Discontinue Certain One A Day Men’s Pre-Conception Health Complete Multivitamin Claims
Mar 31 2026
Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

Financials

Revenue
€45.58 B
Market Cap
€39 B
EPS
-3.68
Dividend Yield
0.27%

Community Chat

Ask AI

6ix6ix